Clinical Trials Browser

Carcinoma, Hepatocellular × BID protein, human × Clear all

NCT03516071 2019-09-04

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular